Admission Date:  [**2119-9-27**]              Discharge Date:   [**2119-9-29**]

Date of Birth:  [**2036-7-6**]             Sex:   F

Service: MEDICINE

Allergies:
Patient recorded as having No Known Allergies to Drugs

Attending:[**First Name3 (LF) 5119**]
Chief Complaint:
Hypercarbic respiratory failure

Major Surgical or Invasive Procedure:
none

History of Present Illness:
Initial history and physical is as per the [**Hospital Unit Name 153**] team
.
This is a 83yoF with COPD on 3L home O2 and diastolic CHF who
represents after having being discharged to her NF earlier today
after admission for hypercarbic respiratory failure in the
setting of COPD exacerbation and HAP. Per pt's daughter, the NF
called her b/c pt was combative and refusing her meals which
usually happens in the setting hypercarbia. She was transferred
to [**Hospital1 18**] ED for further evaluation.
.
In the ED, initially vitals were T 98.1 BP 160/76 HR 86 RR 32
sat 98% 2L NC. ABG 7.25/116/74 on 2L NC, pt refused BIPAP. She
was otherwise afebrile but tachypneic w/ RR 30 BP 146/58 HR 87.
She received Furosemide 40mg IV x 1, Vancomycin 1g IV x 1.

.
Currently, the pt feels well, denies SOB, cough. She is unaware
of the reason for her admission. Her complete ROS is negative at
this time.


Past Medical History:
-HTN
-Type 2 DM
-CVA: bleeding aneurysm x 2, s/p clipping
-CHF: diastolic ([**Hospital1 112**]: ef 75%)
-COPD: FEV1 0.46, 27%; FVC 0.48, 20%
-Seizure d/o (further details unknown)
-Aortic stenosis


Social History:
Lives with daughter. Smoked 1ppd x 30-40 years, quit [**2105**].


Family History:
NC

Physical Exam:
Vitals: T 97.8 HR 90 BP 146/44 RR 32 sat90% 2LNC
GEN: elderly, combative alternating w/lethargy
HEENT: pupils do not react BL, EOMI, MMM
Neck: Supple, no LAD
Resp: decreased air movement BL, expiratory wheezes soft,
diffuse
Card: S1S2, borderline tachy with III/VI systolic murmur at base

that radiates to her neck
Abd: Soft, +BS, NT, distended
Extr: No LE edema b/l
Neuro: oriented only to self, weak on left

Pertinent Results:
[**2119-9-27**] 06:37AM   WBC-6.7 RBC-3.57* HGB-8.6* HCT-30.6* MCV-86
MCH-24.2* MCHC-28.2* RDW-18.2*
[**2119-9-27**] 06:37AM   PLT COUNT-238
[**2119-9-27**] 06:37AM   GLUCOSE-79 UREA N-14 CREAT-0.6 SODIUM-145
POTASSIUM-3.6 CHLORIDE-98 TOTAL CO2-46* ANION GAP-5*
[**2119-9-27**] 08:49PM   LACTATE-0.9
[**2119-9-27**] 09:30PM   PT-12.4 PTT-23.0 INR(PT)-1.0
[**2119-9-27**] 08:49PM   TYPE-ART PO2-74* PCO2-116* PH-7.25* TOTAL
CO2-53* BASE XS-17
[**2119-9-27**] 09:30PM   ALT(SGPT)-18 AST(SGOT)-19 ALK PHOS-71 TOT
BILI-0.2
[**2119-9-27**] 09:44PM URINE  COLOR-Yellow APPEAR-Clear SP [**Last Name (un) 155**]-1.024
[**2119-9-27**] 09:44PM URINE  BLOOD-NEG NITRITE-NEG PROTEIN-NEG
GLUCOSE-NEG KETONE-NEG BILIRUBIN-NEG UROBILNGN-NEG PH-5.0
LEUK-NEG

Brief Hospital Course:
Mrs. [**Known lastname 6633**] is an 83 year old female with a PMH significant for
COPD, diastolic CHF, Type 2 DM, CVA readmitted after same day
discharge for hypercarbic respiratory failure.
.
# Hypercarbic respiratory failure: Patient with multiple
admissions for hypercarbic respiratory failure secondary to
severe COPD.  Pt was brought back to hospital after becoming
combatative at NH, which according to the pts daughter is a sign
of her respiratory failure.  Most recent intubation [**5-21**].  Pt
refused BIPAP in the ED.  Per discussion with HCP and patient on
admission, patient will not have BiPAP or be intubated.  Last
ABG 7.27/110/121 suggesting acute on chronic respiratory
acidosis.  Patient recovered with minimal intervention.  Patient
received solumedrol on admission.  This was switched to
prednisone which will be rapidly tapered.  Continued on
albuterol/ipratropium nebs, spiriva, salmeterol.  Continue
supplemental O2.
.
# Healthcare associated pneumonia: Patient is a nursing home
resident currently completing a 14 day course of vancomycin and
pip/tazo for HA-pna (complete on [**10-1**]).
.
# Chronic Diastolic CHF: TTE on [**9-18**] demonstrated diastolic
dysfunction and elevated TR gradient consistent with pulmonary
hypertension.  Meds initially held in ICU.  Pt was restarted on
lisinopril, lasix and metoprolol before discharge.
.
# Anemia: stable at baseline with hct of ~25-30.  Pt has a
history of Fe-deficiency anemia and was continued on iron
supplementation.  Pt may benefit from colonoscopy but given pts
poor respiratory status, the risks/benefits need to be further
assessed.
.
# Seizure Hx: Pt was continued on phenytoin.  Levels should
continue to be monitored as an outpatient.
.
# Type 2 DM: BS have been under good control.  Previous notes
indicated pt was on NPH in [**Doctor Last Name **] past but she required minimal
coverage on ISS.  this should continue to be monitored as an
outpatient and NPH should be added if pt starts having
significant blood sugar elevations.
.
#Hyperlipidemia:  Pt was restarted on her statin
.
# PPx: heparin SC, PPI
.
# Code: DNR/DNI after discussion w/pt and her daughter [**Name (NI) 59415**]
who is her HCP.
.
# Dispo:  The patient will be transferred back to Wpoch of
[**Location (un) 55**] for further care

Medications on Admission:
Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Inh Q4H
Ipratropium Bromide 0.02 % Inh Q6H
Aspirin 81 mg PO DAILY
Calcium Carbonate 500 mg Tablet PO TID
Ferrous Sulfate 325 mg PO DAILY
Lisinopril 10 mg PO DAILY
Metoprolol Tartrate 50 mg PO BID
Omeprazole 40 mg PO DAILY
Acetaminophen 325 mg PO Q6H as needed.
Guaifenesin 600 mg Tablet Sustained Release PO BID
Camphor-Menthol 0.5-0.5 % Lotion Topical QID
Phenytoin Sodium Extended 200 mg PO TID
Furosemide 20 mg PO DAILY
Piperacillin-Tazobactam-Dextrs 4.5 gram IV Q8H for 4 days: Day 1
on [**9-17**]; to complete 14 day course
Prednisone taper by 10mg q 3 days to final of 10mg QD: 30 mg
started on [**9-26**]
Vancomycin 1 gram IV Q 24H: Day 1 on [**9-17**]; to complete 14 day
course
Polyethylene Glycol 3350 100 % Powder PO DAILY as needed
Docusate Sodium 100 mg PO BID
Senna 8.6 mg PO BID
insulin sliding scale

Discharge Medications:
1. Piperacillin-Tazobactam-Dextrs 4.5 gram/100 mL Piggyback Sig:
One (1)  Intravenous Q8H (every 8 hours): Continue through
[**2119-10-1**].
2. Vancomycin in Dextrose 1 gram/200 mL Piggyback Sig: One (1)
Intravenous Q24H (every 24 hours): Continue through [**2119-10-1**].
3. Pravastatin 20 mg Tablet Sig: Two (2) Tablet PO DAILY
(Daily).
4. Ferrous Sulfate 325 mg (65 mg Iron) Tablet Sig: One (1)
Tablet PO three times a day.
5. Tiotropium Bromide 18 mcg Capsule, w/Inhalation Device Sig:
One (1) Cap Inhalation DAILY (Daily).
6. Salmeterol 50 mcg/Dose Disk with Device Sig: One (1) Disk
with Device Inhalation Q12H (every 12 hours).
7. Omeprazole 20 mg Capsule, Delayed Release(E.C.) Sig: Two (2)
Capsule, Delayed Release(E.C.) PO DAILY (Daily).
8. Aspirin 81 mg Tablet, Chewable Sig: One (1) Tablet, Chewable
PO DAILY (Daily).
9. Albuterol Sulfate 2.5 mg /3 mL (0.083 %) Solution for
Nebulization Sig: [**12-14**] puff Inhalation Q4H (every 4 hours).
10. Phenytoin Sodium Extended 100 mg Capsule Sig: Two (2)
Capsule PO TID (3 times a day).
11. Senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a
day) as needed.
12. Docusate Sodium 100 mg Capsule Sig: One (1) Capsule PO BID
(2 times a day).
13. Lisinopril 10 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
14. Metoprolol Tartrate 50 mg Tablet Sig: One (1) Tablet PO BID
(2 times a day).
15. Prednisone 20 mg Tablet Sig: Two (2) Tablet PO DAILY
(Daily): x 1 more day then change to 20mg po daily x 3 days then
discontinue.
16. Acetaminophen 325 mg Tablet Sig: Two (2) Tablet PO q4h prn
as needed for fever or pain.
17. Furosemide 20 mg Tablet Sig: One (1) Tablet PO DAILY
(Daily).
18. Insulin Lispro 100 unit/mL Solution Sig: One (1)
Subcutaneous ASDIR (AS DIRECTED): as per sliding scale.
19. Calcium 500 with Vitamin D 500 (1,250)-200 mg-unit Tablet
Sig: One (1) Tablet PO three times a day.


Discharge Disposition:
Extended Care

Facility:
[**Hospital1 599**] of [**Location (un) 55**]

Discharge Diagnosis:
Hypercarbic respiratory failure


Discharge Condition:
Fair


Discharge Instructions:
-Transfer to [**Hospital1 1501**] for further care.
-Continue Antibiotics (Vancomycin and Zosyn) through [**2119-10-1*